High Tower Advisors, LLC Trevena Inc Transaction History

High Tower Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$0.16 - $100.0 $2,960 - $1.85 Million	18,506 New	18,506 $3,000
Q2 2022 Aug 10, 2022	SELL	$0.2 - $0.5 $3,883 - $9,708	-19,416 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.41 - $0.63 $354 - $544	865 Added 4.66%	19,416 $11,000
Q4 2021 Feb 10, 2022	BUY	$0.57 - $1.29 $869 - $1,967	1,525 Added 8.96%	18,551 $11,000
Q3 2021 Nov 12, 2021	BUY	$1.11 - $1.7 $3,535 - $5,414	3,185 Added 23.01%	17,026 $21,000
Q2 2021 Aug 06, 2021	BUY	$1.46 - $2.25 $1,241 - $1,912	850 Added 6.54%	13,841 $23,000
Q1 2021 May 10, 2021	BUY	$1.77 - $2.93 $22,994 - $38,063	12,991 New	12,991 $24,000
Q4 2018 Feb 14, 2019	SELL	$0.39 - $3.47 $5,851 - $52,067	-15,005 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.22 - $2.79 $33,311 - $41,863	15,005	15,005 $38,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $273M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.